Wells Fargo & Company vs AstraZeneca PLC
Market cap comparison over time
Wells Fargo & Company
$250.9B
Rank #61
AstraZeneca PLC
$258.3B
Rank #56
Market Cap Over Time
Key Moments
- AstraZeneca PLC overtook Wells Fargo & Company by 1996
- Wells Fargo & Company overtook AstraZeneca PLC by 1997
- AstraZeneca PLC overtook Wells Fargo & Company by 2020
- Wells Fargo & Company overtook AstraZeneca PLC by 2024
- AstraZeneca PLC overtook Wells Fargo & Company by 2026
Year-by-Year Comparison
| Year | Wells Fargo & Company | AstraZeneca PLC | Leader |
|---|---|---|---|
| 2026 | $250.9B | $258.3B | AstraZeneca PLC |
| 2025 | $282.2B | $282.2B | Wells Fargo & Company |
| 2024 | $208.2B | $196.9B | Wells Fargo & Company |
| 2023 | $142.1B | $198.1B | AstraZeneca PLC |
| 2022 | $115.6B | $195.3B | AstraZeneca PLC |
| 2021 | $131.2B | $163.9B | AstraZeneca PLC |
| 2020 | $81.4B | $136.9B | AstraZeneca PLC |
| 2019 | $139.6B | $132.8B | Wells Fargo & Company |
| 2018 | $114.9B | $97.9B | Wells Fargo & Company |
| 2017 | $147.0B | $85.9B | Wells Fargo & Company |
| 2016 | $129.9B | $64.5B | Wells Fargo & Company |
| 2015 | $124.1B | $76.6B | Wells Fargo & Company |
| 2014 | $121.9B | $76.2B | Wells Fargo & Company |
| 2013 | $98.2B | $61.7B | Wells Fargo & Company |
| 2012 | $71.8B | $46.3B | Wells Fargo & Company |
| 2011 | $56.4B | $42.7B | Wells Fargo & Company |
| 2010 | $62.3B | $40.3B | Wells Fargo & Company |
| 2009 | $53.9B | $38.9B | Wells Fargo & Company |
| 2008 | $57.5B | $32.3B | Wells Fargo & Company |
| 2007 | $56.5B | $32.3B | Wells Fargo & Company |
| 2006 | $64.3B | $39.1B | Wells Fargo & Company |
| 2005 | $55.1B | $34.5B | Wells Fargo & Company |
| 2004 | $52.7B | $25.2B | Wells Fargo & Company |
| 2003 | $48.4B | $32.9B | Wells Fargo & Company |
| 2002 | $37.4B | $23.4B | Wells Fargo & Company |
| 2001 | $33.9B | $30.5B | Wells Fargo & Company |
| 2000 | $42.5B | $33.1B | Wells Fargo & Company |
| 1999 | $30.2B | $25.7B | Wells Fargo & Company |
| 1998 | $29.3B | $27.2B | Wells Fargo & Company |
| 1997 | $27.8B | $21.4B | Wells Fargo & Company |
| 1996 | $15.3B | $16.3B | AstraZeneca PLC |
| 1995 | $11.3B | $11.1B | Wells Fargo & Company |
| 1994 | $7.7B | $7.5B | Wells Fargo & Company |